Glucosamine, a popular joint supplement, linked to faster Alzheimers progression

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest the popular joint supplement may intensify an abnormal sugar-tagging process in the Alzheimers brain, although researchers say clinical trials are needed to determine whether it actually causes harm.